Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen B Fox

Showing results (31-40 of 258) with videos related to

Pageof 26
Sort By:
Histopathology|February 18, 2017
GATA3 expression in triple-negative breast cancersDavid J Byrne, Siddhartha Deb, Elena A Takano, et al.
Journal of Clinical Pathology|February 26, 2013
HER2-positive breast cancer metastatic to intracranial meningioma: a case reportMikkaela McCormack, Cesar Salinas-La Rosa, Michael Murphy, et al.
Archives of Pathology & Laboratory Medicine|June 3, 2011
Where and by whom should gastric cancer HER2/neu status be assessed?: lessons from breast cancerManuel Salto-Tellez, Ee Xuan Yau, Benedict Yan, et al.
BMC Research Notes|July 10, 2008
Detection of the transforming AKT1 mutation E17K in non-small cell lung cancer by high resolution meltingHongdo Do, Benjamin Solomon, Paul L Mitchell, et al.
Journal of the National Cancer Institute. Monographs|November 2, 2011
Positron emission tomography and neoadjuvant therapy of breast cancerAlexandre Cochet, Daniele Generali, Stephen B Fox, et al.
BMC Cancer|May 23, 2008
High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsiesHongdo Do, Michael Krypuy, Paul L Mitchell, et al.
Pathology|January 5, 2017
Tumour-infiltrating lymphocytes and the emerging role of immunotherapy in breast cancerStephen J Luen, Peter Savas, Stephen B Fox, et al.
Histopathology|December 5, 2022
Survey of recurrent diagnostic challenges in breast phyllodes tumoursBenjamin Yongcheng Tan, Stephen B Fox, Sunil R Lakhani, et al.
Journal of Clinical Pathology|February 26, 2015
Low-grade fibromatosis-like spindle cell carcinomas of the breast are molecularly exiguousElena A Takano, Sally M Hunter, Ian G Campbell, et al.
Expert Opinion on Therapeutic Targets|May 17, 2014
Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall?Francesca Bedussi, Alberto Bottini, Maurizio Memo, et al.
Pageof 26

Showing results (31-40 of 258) with videos related to

Sort By:
Pageof 26
Histopathology|February 18, 2017
GATA3 expression in triple-negative breast cancersDavid J Byrne, Siddhartha Deb, Elena A Takano, et al.
Journal of Clinical Pathology|February 26, 2013
HER2-positive breast cancer metastatic to intracranial meningioma: a case reportMikkaela McCormack, Cesar Salinas-La Rosa, Michael Murphy, et al.
Archives of Pathology & Laboratory Medicine|June 3, 2011
Where and by whom should gastric cancer HER2/neu status be assessed?: lessons from breast cancerManuel Salto-Tellez, Ee Xuan Yau, Benedict Yan, et al.
BMC Research Notes|July 10, 2008
Detection of the transforming AKT1 mutation E17K in non-small cell lung cancer by high resolution meltingHongdo Do, Benjamin Solomon, Paul L Mitchell, et al.
Journal of the National Cancer Institute. Monographs|November 2, 2011
Positron emission tomography and neoadjuvant therapy of breast cancerAlexandre Cochet, Daniele Generali, Stephen B Fox, et al.
BMC Cancer|May 23, 2008
High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsiesHongdo Do, Michael Krypuy, Paul L Mitchell, et al.
Pathology|January 5, 2017
Tumour-infiltrating lymphocytes and the emerging role of immunotherapy in breast cancerStephen J Luen, Peter Savas, Stephen B Fox, et al.
Histopathology|December 5, 2022
Survey of recurrent diagnostic challenges in breast phyllodes tumoursBenjamin Yongcheng Tan, Stephen B Fox, Sunil R Lakhani, et al.
Journal of Clinical Pathology|February 26, 2015
Low-grade fibromatosis-like spindle cell carcinomas of the breast are molecularly exiguousElena A Takano, Sally M Hunter, Ian G Campbell, et al.
Expert Opinion on Therapeutic Targets|May 17, 2014
Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall?Francesca Bedussi, Alberto Bottini, Maurizio Memo, et al.
Pageof 26